ArticleNeurobiology of disease2026
The PINK1-VCP-p47 pathway protects against tau-induced dendritic shrinkage in cortical neurons through interaction with STIP1.
Article in Neurobiology of disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
6 authors.
Funding
Abstract
Microtubule-associated protein tau (MAPT) contributes to the pathogenesis of Alzheimer's disease (AD) and some forms of Frontotemporal Lobar Dementia wherein dendritic simplification is strongly related to cognitive dysfunction. Loss of function mutations in PTEN-induced kinase 1 (PINK1) cause recessive early-onset Parkinson's disease with dementia, and reduced wild-type PINK1 expression is observed in sporadic AD. We previously found that PINK1 interacts with valosin-containing protein (VCP) and promotes phosphorylation of the VCP co-factor NSFL1C (p47). This study was designed to test the hypothesis that PINK1 rescues tau-induced dendritic simplification through the VCP-p47 pathway, and to define neuroprotective mechanisms downstream of p47 phosphorylation. Mouse primary cortical neurons were transfected with 2N4R-Tau and plasmids encoding components of the PINK1-VCP-p47 signaling pathway and the impact on tau-mediated dendritic injury was assessed. Immunoprecipitation-mass spectrometry, immunoblotting, RNAi and Sholl analysis were performed to define downstream mechanisms of neuroprotection. Tau-induced dendritic shortening and simplification was fully rescued by co-expression of PINK1, VCP, p47 or the p47-S176D phosphomimic (p47D), but not by the non-phosphorylatable p47-S176A (p47A) variant. Pathway analysis showed enhanced interactions of p47D with proteins in the Rho-GTPase pathway. Immunoprecipitation confirmed that STIP1 interacts with p47D to a significantly higher degree than p47A. Overexpression of STIP1 rescued tau-mediated dendritic simplification. Moreover, STIP1 siRNA impaired the neuroprotective effects of both PINK1 and p47D, indicating an essential role in the PINK1-p47D neuroprotection pathway. The current study highlights a novel PINK1-(phospho)p47-STIP1 signaling axis that promotes dendritic complexity and protects against tau-induced neurodegeneration in cortical neurons.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.